ACTS Long 600mg effervescent tablets, No. 20

Diseases of the respiratory system, accompanied by the formation of viscous, difficult to separate sputum:

• acute and chronic bronchitis, obstructive bronchitis;

• tracheitis, laryngotracheitis;

• pneumonia;

• lung abscess;

• bronchiectasis, bronchial asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis;

• cystic fibrosis;

• Acute and chronic sinusitis, otitis media (otitis media).

Inside, after eating.
Effervescent tablets should be dissolved in one glass of water. The tablets should be taken immediately
after dissolution, in exceptional cases, you can leave the solution ready for use
for 2 hours. Additional fluid intake enhances the mucolytic effect of the drug. For
short-term colds, the duration of admission is 5-7 days. In
chronic bronchitis and cystic fibrosis, the drug should be taken for a longer time
to achieve a prophylactic effect.
In the absence of other prescriptions, it is recommended to adhere to the following dosages:
Mucolytic therapy:
Adults and children over 14 years old: 1 effervescent tablet once a day (600 mg).

1 effervescent tablet contains:

active substance: acetylcysteine ??- 600.00 mg;

excipients: citric acid - 625.00 mg; sodium bicarbonate - 327.00 mg; sodium carbonate - 104.00 mg; mannitol - 72.80 mg; lactose - 70.00 mg; ascorbic acid - 75.00 mg; sodium cyclamate - 30.75 mg; sodium saccharinate dihydrate - 5.00 mg; sodium citrate dihydrate - 0.45 mg; blackberry flavoring 'B' - 40.00 mg.

• Hypersensitivity to acetylcysteine ??or other components of the drug;

• peptic ulcer of the stomach and duodenum in the acute stage;

• hemoptysis, pulmonary bleeding;

• pregnancy;

• lactation period;

• children under 14 years of age (for this dosage form);

• lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Pharmacological action
Mucolytic drug. Acetylcysteine ??is a derivative of the amino acid cysteine. It has a mucolytic effect, facilitates the discharge of sputum due to a direct effect on the rheological properties of sputum. The action is due to the ability to break disulfide bonds of mucopolysaccharide chains and cause depolymerization of mucoproteins in sputum, which leads to a decrease in the viscosity of sputum. The drug remains active in the presence of purulent sputum.
Side effects
Erysipelas, stomatitis, abdominal pain, nausea, vomiting, diarrhea, heartburn, dyspepsia, tinnitus, headache, fever, isolated reports of bleeding due to hypersensitivity reactions, decreased platelet aggregation.
Overdose
Symptoms: With an erroneous or deliberate overdose, phenomena such as diarrhea, vomiting, stomach pain, heartburn and nausea are observed.
Treatment: symptomatic.